NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Jan. 12, 2006--Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that its CombiMatrix group has entered into a non-exclusive distribution agreement with Cold Spring Biotech to distribute CombiMatrix products and services in mainland China, Taiwan, and Hong Kong. Under the terms of the agreement, Cold Spring Biotech will market and sell CustomArrays(TM) and CatalogArrays(TM), including the recently introduced Influenza A Research Microarray. Cold Spring Biotech has three offices in Taiwan (Taipei, Taichung, and Tainan) and five offices in Mainland China (Beijing, Shanghai, Kwang Chou, Chendu, and Wuhan). With this distributed network and appropriate contacts, Cold Spring Biotech will market CombiMatrix products in rapidly growing markets and is positioned to provide CombiMatrix’s Influenza A Research Microarrays for testing of Influenza H5N1.